{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:40:34Z","timestamp":1777354834739,"version":"3.51.4"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Opioid use impairs immune response, but the mechanism of action underlying this effect remains unknown. In people with HIV-1 (PWH), including those on suppressive antiretroviral therapy (ART), opioid use may exacerbate chronic inflammation. To address this knowledge gap, we sought to identify immune biomarkers in virally suppressed PWH on medications for opioid use disorder (MOUD), including methadone (MET) and suboxone (SUB), and to assess possible associations with clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study enrolled PWH receiving ART from the Philadelphia FIGHT Treatment Center in three groups based on their medication regimen: control (no known opioid use, no MOUD, n = 14), SUB (n = 15), and MET (n = 14). Plasma samples were analyzed with the SomaScan platform for differentially expressed proteins. Based on protein signature modeling, SomaSignal tests were evaluated for clinically relevant information about participant health and risk status. Between-group differences were tested using Wilcoxon rank-sum test and beta regression; p values were adjusted for false discovery rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mean age of participants was 48.6 years and the mean ART duration was 10.4 years, showing consistency across all groups. However, the proportion of female participants was lower in the control group (14.3%) versus the SUB (40.0%) and MET (42.9%) groups. The SomaScan assay revealed 12 unique proteins, identified by 13 SOMAmers, that were differentially expressed between the control and MOUD groups. Specifically, PWH on MOUD exhibited higher levels of HSP70, KERA, NTR1, FLRT2, sCD14, SDF-1, IGLL1, AT1B2, and ROR1, while the control group had higher levels of MMAC, IGFALS, and ELA2A (p &amp;lt; 0.001). ELISA analysis corroborated the findings, showing that results for HSP70, IGLL1, and sCD14 were concordant with SomaScan results. SomaSignal tests indicated that PWH receiving MET had possible higher risks for kidney disease, heart failure, and dementia, alongside trends suggesting reduced visceral fat and alcohol impact versus other groups. The increased risks for kidney disease and dementia were confirmed using beta regression analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These data suggest that PWH chronically exposed to MOUD have higher levels of circulating protein biomarkers that may be linked to increased risk of adverse clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmolb.2026.1728953","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:52:04Z","timestamp":1777351924000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating plasma protein biomarkers associated with risk of negative clinical outcomes in virally suppressed people with HIV receiving medications for opioid use disorder"],"prefix":"10.3389","volume":"13","author":[{"given":"Livio","family":"Azzoni","sequence":"first","affiliation":[{"name":"HIV Cure and Viral Diseases Center, The Wistar Institute","place":["Philadelphia, PA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc.","place":["Foster City, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyi","family":"Zhu","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc.","place":["Foster City, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Fair","sequence":"additional","affiliation":[{"name":"HIV Cure and Viral Diseases Center, The Wistar Institute","place":["Philadelphia, PA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Hiserodt","sequence":"additional","affiliation":[{"name":"Philadelphia FIGHT","place":["Philadelphia, PA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karam","family":"Mounzer","sequence":"additional","affiliation":[{"name":"Philadelphia FIGHT","place":["Philadelphia, PA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey J.","family":"Wallin","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc.","place":["Foster City, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis J.","family":"Montaner","sequence":"additional","affiliation":[{"name":"HIV Cure and Viral Diseases Center, The Wistar Institute","place":["Philadelphia, PA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhui","family":"Cai","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc.","place":["Foster City, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1038\/s41380-024-02620-7","article-title":"The single-cell opioid responses in the context of HIV (SCORCH) consortium","volume":"29","author":"Ament","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/adb.12156","article-title":"Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity","volume":"20","author":"Araos","year":"2015","journal-title":"Addict. Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s11481-020-09959-y","article-title":"Effect of opioid use on immune activation and HIV persistence on ART","volume":"15","author":"Azzoni","year":"2020","journal-title":"J. Neuroimmune Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/jlb.4a1221-678rr","article-title":"Methadone use is associated with increased levels of sCD14, immune activation, and inflammation during suppressed HIV infection","volume":"112","author":"Azzoni","year":"2022","journal-title":"J. Leukoc. Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.4049\/jimmunol.1401417","article-title":"Functions of heat shock proteins in pathways of the innate and adaptive immune system","volume":"193","author":"Binder","year":"2014","journal-title":"J. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.eplepsyres.2010.06.015","article-title":"Expression patterns of AMOG in developing human cortex and malformations of cortical development","volume":"91","author":"Boer","year":"2010","journal-title":"Epilepsy Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1002\/ijc.26208","article-title":"The neurotensin receptor-1 promotes tumor development in a sporadic but not an inflammation-associated mouse model of colon cancer","volume":"130","author":"Bugni","year":"2012","journal-title":"Int. J. Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3390\/pharmacy8030168","article-title":"Opioid use disorders in people living with HIV\/AIDS: a review of implications for patient outcomes, drug interactions, and neurocognitive disorders","volume":"8","author":"Cernasev","year":"2020","journal-title":"Pharm. (Basel)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/cmi.2017.30","article-title":"The functions of tumor suppressor PTEN in innate and adaptive immunity","volume":"14","author":"Chen","year":"2017","journal-title":"Cell Mol. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.30773\/pi.2022.0004","article-title":"Differential gene expression in the hippocampi of nonhuman primates chronically exposed to methamphetamine, cocaine, or heroin","volume":"19","author":"Choi","year":"2022","journal-title":"Psychiatry Investig."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e2059","DOI":"10.1093\/cid\/ciaa1928","article-title":"Incident non-AIDS comorbidity burden among women with or at risk for human immunodeficiency virus in the United States","volume":"73","author":"Collins","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.36518\/2689-0216.1680","article-title":"Extended-release buprenorphine could overcome barriers to medical treatment of opioid use disorder in at-risk populations","volume":"6","author":"Davis","year":"2025","journal-title":"HCA Healthc. J. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/s0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","article-title":"Systemic effects of inflammation on health during chronic HIV infection","volume":"39","author":"Deeks","year":"","journal-title":"Immunity"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1016\/s2214-109x(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1111\/j.1476-5381.2011.01513.x","article-title":"Opioids and the immune system: what is their mechanism of action?","volume":"164","author":"Eisenstein","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/s41588-019-0470-3","article-title":"CELA2A mutations predispose to early-onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activation","volume":"51","author":"Esteghamat","year":"2019","journal-title":"Nat. Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1162004","DOI":"10.3389\/fimmu.2023.1162004","article-title":"Fibronectin leucine-rich transmembrane protein 2 drives monocyte differentiation into macrophages via the UNC5B-Akt\/mTOR axis","volume":"14","author":"Fang","year":"2023","journal-title":"Front. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"840","DOI":"10.2174\/1381612820666141027124915","article-title":"The roles of neurotensin and its analogues in pain","volume":"21","author":"Feng","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"B20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/s0034-7094(12)70169-1","article-title":"Opioids and the immune system: clinical relevance","volume":"62","author":"Garcia","year":"2012","journal-title":"Rev. Bras. Anestesiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"Gold","year":"2010","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.alcohol.2016.09.029","article-title":"Atp1a2 contributes modestly to alcohol-related behaviors","volume":"56","author":"Gritz","year":"2016","journal-title":"Alcohol"},{"key":"B23","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.36076\/ppj.2020\/23\/E41","article-title":"An analysis of biomarkers in patients with chronic pain","volume":"23","author":"Gunn","year":"2020","journal-title":"Pain Physician"},{"key":"B24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1189\/jlb.0710402","article-title":"Opioid-induced chemokine expression requires NF-\u03baB activity: the role of PKC\u03b6","volume":"89","author":"Happel","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"938","DOI":"10.4252\/wjsc.v12.i9.938","article-title":"Role of the CXCR4-SDF1-HMGB1 pathway in the directional migration of cells and regeneration of affected organs","volume":"12","author":"Haque","year":"2020","journal-title":"World J. Stem Cells"},{"key":"B26","unstructured":"Global state of harm reduction: 2023 update to key data\n          \n          \n          2023"},{"key":"B27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/qai.0000000000002893","article-title":"Impact of heroin and HIV on gut integrity and immune activation","volume":"89","author":"Hileman","year":"2022","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"B28","unstructured":"The path that ends AIDS: UNAIDS global AIDS update 2023\n          \n          \n          2023"},{"key":"B29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1089\/dna.1987.6.163","article-title":"Characterization of pancreatic elastase II cDNAs: two elastase II mRNAs are expressed in human pancreas","volume":"6","author":"Kawashima","year":"1987","journal-title":"DNA"},{"key":"B30","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3390\/pathogens13060474","article-title":"The anti-inflammatory effect of SDF-1 derived peptide on Porphyromonas gingivalis infection via regulation of NLRP3 and AIM2 inflammasome","volume":"13","author":"Kim","year":"2024","journal-title":"Pathogens"},{"key":"B31","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/imr.12065","article-title":"Immune activation and HIV persistence: implications for curative approaches to HIV infection","volume":"254","author":"Klatt","year":"2013","journal-title":"Immunol. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3892\/ijo.21.3.469","article-title":"MMAC\/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer","volume":"21","author":"Koul","year":"2002","journal-title":"Int. J. Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1016\/j.neurobiolaging.2015.07.018","article-title":"Heroin abuse exaggerates age-related deposition of hyperphosphorylated tau and p62-positive inclusions","volume":"36","author":"Kovacs","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1021\/acs.jproteome.4c00411","article-title":"Crossing the halfway point: aptamer-based, highly multiplexed assay for the assessment of the proteome","volume":"23","author":"Kraemer","year":"2024","journal-title":"J. Proteome Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/b978-0-12-407707-2.00002-3","article-title":"Residual immune dysregulation syndrome in treated HIV infection","volume":"119","author":"Lederman","year":"2013","journal-title":"Adv. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/COH.0b013e32835c7134","article-title":"Soluble biomarkers of HIV transmission, disease progression and comorbidities","volume":"8","author":"Leeansyah","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1016\/j.bbamcr.2016.07.009","article-title":"Heterodimerization of the kappa opioid receptor and neurotensin receptor 1 contributes to a novel \u03b2-arrestin-2\u2013biased pathway","volume":"1863","author":"Liu","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e207954","DOI":"10.1001\/jamanetworkopen.2020.7954","article-title":"Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000-2016","volume":"3","author":"Marcus","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1534\/g3.117.043018","article-title":"A SINE insertion in ATP1B2 in Belgian shepherd dogs affected by spongy degeneration with cerebellar ataxia (SDCA2)","volume":"7","author":"Mauri","year":"2017","journal-title":"G3 (Bethesda)."},{"key":"B40","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1365-2257.1990.tb00038.x","article-title":"Differences between the effects of EDTA and citrate anticoagulants on platelet count and mean platelet volume","volume":"12","author":"McShine","year":"1990","journal-title":"Clin. Lab. Haematol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"101392","DOI":"10.1016\/j.eclinm.2022.101392","article-title":"Health conditions in adults with HIV compared with the general population: a population-based cross-sectional analysis","volume":"47","author":"Morales","year":"2022","journal-title":"EClinicalMedicine"},{"key":"B42","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41385-021-00375-w","article-title":"Epithelial production of elastase is increased in inflammatory bowel disease and causes mucosal inflammation","volume":"14","author":"Motta","year":"2021","journal-title":"Mucosal Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"10299","DOI":"10.1038\/s41467-024-54717-w","article-title":"Systemic biological mechanisms underpin poor post-discharge growth among severely wasted children with HIV","volume":"15","author":"Mudibo","year":"2024","journal-title":"Nat. Commun."},{"key":"B44","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.biomaterials.2015.10.052","article-title":"Early in-situ cellularization of a supramolecular vascular graft is modified by synthetic stromal cell-derived factor-1\u03b1 derived peptides","volume":"76","author":"Muylaert","year":"2016","journal-title":"Biomaterials"},{"key":"B45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/QCO.0b013e32835ba6b1","article-title":"Life expectancy living with HIV: recent estimates and future implications","volume":"26","author":"Nakagawa","year":"2013","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e041734","DOI":"10.1136\/bmjopen-2020-041734","article-title":"Excess burden of age-associated comorbidities among people living with HIV in British Columbia, Canada: a population-based cohort study","volume":"11","author":"Nanditha","year":"2021","journal-title":"BMJ Open"},{"key":"B47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/cei.12814","article-title":"Ageing and inflammation in patients with HIV infection","volume":"187","author":"Nasi","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00726-011-1163-0","article-title":"Role of the mu-opioid receptor in opioid modulation of immune function","volume":"45","author":"Ninkovi\u0107","year":"2013","journal-title":"Amino Acids"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2361176","DOI":"10.1080\/25787489.2024.2361176","article-title":"Comorbidity and polypharmacy among people with HIV stratified by age, sex, and race","volume":"25","author":"Paudel","year":"2024","journal-title":"HIV Res. Clin. Pract."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e0243529","DOI":"10.1371\/journal.pone.0243529","article-title":"Comorbidities in people living with HIV: an epidemiologic and economic analysis using a claims database in France","volume":"15","author":"Pourcher","year":"2020","journal-title":"PLoS One"},{"key":"B51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1468-1293.2005.00263.x","article-title":"Pancreatic exocrine insufficiency in HIV-positive patients","volume":"6","author":"Price","year":"2005","journal-title":"HIV Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s11481-011-9292-5","article-title":"Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections","volume":"6","author":"Roy","year":"2011","journal-title":"J. Neuroimmune Pharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"Sandler","year":"2011","journal-title":"J. Infect. Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jneuroim.2003.11.006","article-title":"Morphine-induced alterations of immune status are blocked by the dopamine D2-like receptor agonist 7-OH-DPAT","volume":"148","author":"Saurer","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11904-018-0393-0","article-title":"Challenges facing a rural opioid epidemic: treatment and prevention of HIV and hepatitis C","volume":"15","author":"Schranz","year":"2018","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"E189","DOI":"10.1097\/JAN.0000000000000392","article-title":"A comparison of medication-assisted treatment options for opioid addiction: a review of the literature","volume":"34","author":"Spayde-Baker","year":"2023","journal-title":"J. Addict. Nurs."},{"key":"B57","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12974-015-0288-6","article-title":"Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals","volume":"12","author":"Suh","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"B58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1101\/cshperspect.a036996","article-title":"The role of PTEN in innate and adaptive immunity","volume":"9","author":"Taylor","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"G894","DOI":"10.1152\/ajpgi.00373.2005","article-title":"Zymogen activation in a reconstituted pancreatic acinar cell system","volume":"290","author":"Thrower","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B60","volume-title":"Buprenorphine-naloxone film versus tablets for opioid use disorder. CADTH health technology review","author":"Tingley","year":"2023"},{"key":"B61","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1097\/psy.0000000000001127","article-title":"Suicidality among people living with HIV from 2010 to 2021: a systematic review and a meta-regression","volume":"84","author":"Tsai","year":"2022","journal-title":"Psychosom. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s11606-020-06389-7","article-title":"Prevalence and medication treatment of opioid use disorder among primary care patients with hepatitis C and HIV","volume":"36","author":"Tsui","year":"2021","journal-title":"J. Gen. Intern Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/eurpub\/ckae031","article-title":"Mortality and comorbidities in a nationwide cohort of HIV-infected adults: comparison to a matched non-HIV adults' cohort, France, 2006-18","volume":"34","author":"Vall\u00e9e","year":"2024","journal-title":"Eur. J. Public Health"},{"key":"B64","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fendo.2012.00184","article-title":"Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy","volume":"3","author":"Wu","year":"2012","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B66","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.drugalcdep.2014.03.005","article-title":"Chronic morphine treatment induces over-expression of HSP70 in mice striatum related with abnormal ubiquitin-proteasome degradation","volume":"139","author":"Yang","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/srep01542","article-title":"Drug addiction is associated with leukocyte telomere length","volume":"3","author":"Yang","year":"2013","journal-title":"Sci. Rep."},{"key":"B67","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/23744235.2017.1370126","article-title":"Exocrine pancreatic insufficiency is common in people living with HIV on effective antiretroviral therapy","volume":"50","author":"Yilmaz","year":"2018","journal-title":"Infect. Dis. (Lond)."},{"key":"B68","first-page":"153","article-title":"Alterations of immune functions in heroin addicts","volume":"13","author":"Zaki","year":"2006","journal-title":"Egypt J. Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13000-015-0356-3","article-title":"The significance of NTR1 expression and its correlation with \u03b2-catenin and EGFR in gastric cancer","volume":"10","author":"Zhou","year":"2015","journal-title":"Diagn. Pathol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/jmv.24419","article-title":"Increased expression and dysregulated association of restriction factors and type I interferon in HIV, HCV mono- and co-infected patients","volume":"88","author":"Zhu","year":"2016","journal-title":"J. Med. Virol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s13365-010-0016-z","article-title":"PTEN gene silencing prevents HIV-1 gp120(IIIB)-induced degeneration of striatal neurons","volume":"17","author":"Zou","year":"2011","journal-title":"J. Neurovirol"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1728953\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:52:20Z","timestamp":1777351940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1728953\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":71,"alternative-id":["10.3389\/fmolb.2026.1728953"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2026.1728953","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"article-number":"1728953"}}